State of the art cGMP facilities for microbial fermentation
We have state-of-the-art facilities for microbial fermentation manufacturing. These physically separated suites are operated by dedicated staff for preclinical, clinical and commercial manufacturing.
We have built a modern and fully integrated environment for the development and production of biological medicines using microbial expression systems. Through working on our own pipeline, we have gained invaluable expertise, insights and experience.
Polpharma Biologics is led by a team with decades of international experience and a proven track record in biologics development, clinical and commercial production, registration and commercialization. All our activities will be supported by our Quality Control and Quality Assurance department.
Microbial manufacturing capacity
Physically separate microbial production suite operated by dedicated staff
cGMP fermentation scale of 500 L/batch (nominal volume) for clinical and commercial supply
Upstream process including primary recovery in stainless steel technology
Downstream process in single-use technology for fast changeover and zero cross-contamination risk
Polpharma Biologics provides drug product development and cGMP manufacturing of sterile biologs in liquid and lyophilized forms at lab and large-scale. See our full range of drug product services.
“We are committed to positive outcomes and delivering projects on time to specification”
Our extensive capacity means we can transfer in external processes or continue with integrated projects. We understand that we are delivering material for pre-clinical, clinical trials and for patients in urgent need of treatment, we always endeavor to get your product to where it needs to be.
PL
EN
